13:00-13:30
Speaker: Heike Angerer, Institut Biochemie II, Goethe-Universität Frankfurt am Main
Chair: Carola Hunte, Institute for Biochemistry and Molecular Biology, University Freiburg
Organizers: Study Group Bioenergetics

The “IMMediate – Immune-Mediated Diseases” program at the Medical Center – University of Freiburg is based in the fields of immunology, oncology and cell biology. It supports Advanced Clinician Scientists who examine immune-mediated diseases that affect e.g. the brain, heart, liver or intestine.

Henning Jessen has received a grant of nearly one million euros from the Volkswagen Foundation.

12:30-13:30
Speaker: Jean-Michel Jault, Research Director of the CNRS, Molecular Microbiology and Structural Biochemistry, IBCP CNRS/Université de Lyon
Chairs:
Lutz Schmitt, Biochemie I, Heinrich Heine Universität Düsseldorf
Joachim Geyer, Institut für Pharmakologie und Toxikologie, Justus-Liebig-Universität Gießen
Organizers: Study Group Biomembranes

“Mathematical modelling of dynamic protein machineries – how to implement modelling in SFB 1381 projects“

Rare genetic variants affecting urine metabolite levels link population variation to inborn errors of metabolism.

12:30-13:30
Speaker: Johannes Herrmann, Technische Universität Kaiserslautern
Chairs: Ralf Erdmann, Ruhr-Universität Bochum; Konstanze Winklhofer, Ruhr-Universität Bochum
Organizers: Study Group Molecular Cell Biology

A total of 6.8 million euros will be used to finance a new trinational PhD programme in immunology research.

For his outstanding work in cancer medicine, Prof. Dr. Robert Zeiser received together with Prof. Dr. Nikolas von Bubnoff of the University of Lübeck the German Cancer Prize 2021 in the translational research category.

12:30-13:00
Speaker: Hauke Hillen, Department of Cellular Biochemistry, University Medical Center Göttingen and Max Planck Institute for Biophysical Chemistry, Göttingen
Chair: Inge Kühl, Institut de Biologie Intégrative de la Cellule, CNRS, Université Paris-Saclay
Organizers: AK Young Investigators

Olaf Groß receives ERC Proof of Concept Grant IMMUNOSTIM to develop immunostimulatory drug candidates.

Baden-Württemberg Ministry of Science, Research and the Arts honors Freiburg medical scientist and epidemiologist.

The German Research Foundation is funding the signalling researcher’s work at the University of Freiburg for five years.

We are happy and proud to announce, that the CRC 992 “Medical Epigenetics – From basic mechanisms to clinical applications” receives funding for another 4 years from the DFG. The DFG senate has decided to extend the funding of the CRC 992 with aprox. 14 Million Euros.

Germany’s most prestigious research funding prize goes to Freiburg-based Max Planck researcher.

Chris Meisinger and collegues discovered link of the mitochondrial presequence processing machinery to a nuclear stress response.

Published by Wolfgang Sippl and Manfred Jung, with further contributions by Michael Lübbert and Stefan Günther.